Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $468,850 - $557,550
-2,500 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $484,425 - $610,350
2,500 New
2,500 $527,000
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $895,680 - $1.15 Million
-4,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $956,223 - $1.25 Million
3,379 Added 544.12%
4,000 $1.14 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $160,839 - $257,534
621 New
621 $215,000
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $220,060 - $304,070
-1,000 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$217.44 - $243.88 $117,417 - $131,695
-540 Reduced 35.06%
1,000 $233,000
Q2 2019

Aug 13, 2019

BUY
$219.29 - $241.72 $65,787 - $72,516
300 Added 24.19%
1,540 $360,000
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $268,720 - $420,310
1,240 New
1,240 $293,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $382,937 - $485,031
-1,375 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $110,066 - $143,936
-375 Reduced 21.43%
1,375 $486,000
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $180,264 - $214,837
700 Added 66.67%
1,750 $508,000
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $693,766 - $981,215
-2,667 Reduced 71.75%
1,050 $288,000
Q4 2017

Feb 13, 2018

BUY
$307.64 - $344.58 $317,484 - $355,606
1,032 Added 38.44%
3,717 $1.18 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $9,559 - $11,209
34 Added 1.28%
2,685 $841,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,651
2,651 $719,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Infrastructure Capital Advisors, LLC Portfolio

Follow Infrastructure Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Infrastructure Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Infrastructure Capital Advisors, LLC with notifications on news.